HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence
Authors:
- Claus HellerbrandCHClaus Hellerbrand
- Andreas PöpplAPAndreas Pöppl
- Arndt HartmannAHArndt Hartmann
- Jürgen SchölmerichJSJürgen Schölmerich
- Guntram LockGLGuntram Lock
- 1 July 2003
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 1 (4) , 279-284
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosisGut, 2000
- Hepatocellular carcinomaThe Lancet, 1999
- Hemochromatosis mutation in hepatitis C: histopathology.Gastroenterology, 1998
- Dietary iron overload as a risk factor for hepatocellular carcinoma in black africansHepatology, 1998
- The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand bindingProceedings of the National Academy of Sciences, 1998
- Iron and neoplasiaJournal of Hepatology, 1998
- The Significance of the 187G (H63D) Mutation in HemochromatosisThe American Journal of Human Genetics, 1997
- A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosisNature Genetics, 1996
- Iron, ferritin, hepatitis B surface and core antigens in the livers of chinese patients with hepatocellular carcinomaCancer, 1987
- Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary HemochromatosisNew England Journal of Medicine, 1985